Safety, Compliance & Longevity

Built to Perform, Proven to Last

KYMIRA’s infrared technology isn’t a coating or treatment—it’s embedded into the fibres themselves. That means:

  • No wash-out: The mineral blend is woven into the yarn, not applied to the surface
  • No degradation: Infrared emission remains stable for the life of the garment
  • No compromise: Fabrics meet global safety and textile standards

🧾 Regulatory Compliance

  • KYMIRA infrared fabric, containing Celliant®, is an FDA-determined Class 1 medical device
  • The FDA has determined that Celliant® products are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products
  • Celliant® is designated as a Class 1 Medical Device in Canada, the UK, EU, Australia, New Zealand, and Japan
  • KYMIRA products are OEKO-TEX® Standard 100 certified and CE approved

🧪 Material Stability

🧪 Material Stability

  • Ceramic particles maintain emissivity across wash cycles
  • Thermal modeling confirms consistent infrared output (Anderson et al., 2016; Anderson et al., 2017)

🧬 Biological Safety

  • No adverse effects reported in clinical trials
  • Used in long-term recovery protocols and sleep studies (Hamblin & Vatansever, 2012; Gordon & Coyle, 2012)

KYMIRA garments are designed to perform at 100% for their full lifespan. No recharge. No reactivation. Just science that stays active.


Published Studies Supporting Safety & Longevity

  • Gordon I, Wason J, Lavery L, Hamblin MR, Thein MS. (2014). Randomized Controlled Trial Comparing the Effects of Far-Infrared Emitting Ceramic Fabric Shirts and Control Polyester Shirts on Transcutaneous PO₂. Journal of Textile Science and Engineering.
  • Anderson DM, Fessler J, Pooley M, Seidel S, Hamblin MR, Beckham H, Brennan JF. (2017). Infrared Radiative Properties and Thermal Modeling of Ceramic-Embedded Textile Fabrics. Biomedical Optics Express.
  • Anderson DM, Pooley M, Beckham HW, Brennan JF. (2016). Engineered Emissivity of Textile Fabrics by the Inclusion of Ceramic Particles. Optics Express.
  • Hamblin MR, Vatansever F. (2012). Far Infrared Radiation (FIR): Its Biological Effects and Medical Applications. Photonics and Lasers in Medicine.
  • Gordon I, Coyle M. (2012). Transcutaneous Partial Pressure of Oxygen (tcPO₂) as a Primary Endpoint to Assess the Efficacy of Celliant® as a Vasoactive Material. Internal Clinical Report.